Omar K. Haffar, Ph.D. Founder, President & CEO
Cell Biologist with 30 years of experience in the Biotech/Pharmaceutical industry. Genentech (South San Francisco, CA), Bristol-Myers Squibb (Seattle, WA), Founder or co-Founder of 3 previous Biotech companies: Cytokine Networks, Inc., (Seattle, WA); International Therapeutics, Inc. (Seattle, WA); Presidio Pharmaceuticals, Inc. (San Francisco, CA). Dr. Haffar is the Chairman of the Board of Presidio Pharmaceuticals and Board member of Naia Limited. Dr. Haffar received his B.Sc. in Biology from the American University of Beirut (Beirut, Lebanon) , his M.Sc. in Physiology from the University of Oregon (Eugene, OR), and his Ph.D. in Physiology/Anatomy from the University of California, Berkeley (Berkeley, CA)
Thomas P. Plotts, MBACFO
23 years of financial experience most recently as Vice President of Finance and CFO of Los Angeles Biomedical Research Institute (Torrance, CA). Experienced in strategic planning and financial management, IPO and secondary offerings, U.S. and GAAP Financials, SEC & financial reporting, investor relations and reporting. Mr. Plotts received his M.B.A. from the Marshall School of Business at University of Southern California (Los Angeles, CA)